#161694

Anti-CD45R monoclonal antibody [GRT22]

Cat. #161694

Anti-CD45R monoclonal antibody [GRT22]

Cat. #: 161694

Sub-type: Primary antibody

Target: CD45R

Class: Monoclonal

Application: FACS; IHC; ELISA; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol

Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service

Primary Citation: Ruiz-Cabello. 1989. Hybridoma. 8(1):1-11. PMID: 2466763

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD45R monoclonal antibody [GRT22]
  • Cancer: Blood cancer
  • Research fields: Cancer
  • Clone: GRT22
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 220 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS; IHC; ELISA; WB
  • Description: CD45R antigenis a glycoprotein that is part of the CD45 complex expressed on human leukocytes
  • Immunogen: B-ALL cells
  • Isotype: IgG1
  • Recommended controls: leukocytes

Target Details

  • Target: CD45R
  • Molecular weight: 220 kDa

Applications

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Ruiz-Cabello. 1989. Hybridoma. 8(1):1-11. PMID: 2466763